IRIS
MINGARI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 31.551
Totale 31.551
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 31.551
Totale 31.551
Salva come PNG Salva come JPEG
Città #
Genova 24.564
Rapallo 2.949
Genoa 2.409
Vado Ligure 1.577
Bordighera 52
Totale 31.551
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stem cell-Natural Killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. 212
Identification of cytomegalovirus (CMV)-specific T lymphocytes displaying an effector-memory phenotype that kill CMV-infected target cells in an HLA-E-restricted fashion 194
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 188
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 171
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 169
Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein 168
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. 164
T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells. 158
Role of the calpain-calpastatin system in the density-dependent growth arrest 157
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 149
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 148
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 147
Markers and function of human NK cells in normal and pathological conditions 147
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 146
Human NK cells at early stages of differentiation produce large amounts of CXCL8 and express CD161 molecule that that functions as an activating receptor 143
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 143
Anticorpo ricombinante umano e suo uso per l’ identificazione del sindecano-1 a scopo diagnostico e terapeutico 141
Effect of tumor cells and tumor microenvironment on NK-cell function. 140
Stimulatory receptors in NK and T cells. 138
Unique Eomes+ NK cell subsets are present in uterus and decidua during early pregnancy 137
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 137
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. 136
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 136
IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors 134
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. 133
Human innate lymphoid cells 133
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK cell function 132
"Physiological and Pathological Aspects of Human NK Cells" 132
Surface antigens specifically expressed by activated T cells in humans. 132
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. 131
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 130
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function 130
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 129
Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. 129
Immunobiology of human NK cells. 128
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 128
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 127
Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. 127
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 127
Surface receptors that regulate the NK cell function: beyond the NK cell scope. 126
Stromal cells from human decidua exert a strong inhibitory effect on NK cell function and dendritic cell differentiation 126
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients 126
Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors. 126
Role of Ia Antigens in the human autologous mixed lymphocyte reaction. 125
MSC and innate immune cell interactions: A lesson from human decidua 125
Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells 125
Human NK receptors: from the molecules to the therapy of high risk leukemias. 125
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 125
Cytolytic T lymphocytes displaying Natural Killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production 124
Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function. 124
Development of human natural killer cells and other innate lymphoid cells. 124
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 124
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 124
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 124
Thymic origin of some natural killer cells: clonal proliferation of human CD3-16+ cells from CD3-4-8- thymocyte precursors requires the presence of H9 leukemic cells. 124
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells 124
Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation 123
Surface markers of resting and activated human T cells. Functional implications and experimental limits. 123
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 123
Characterization of human afferent lymph dendritic cells from seroma fluids. 123
Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts 122
Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias. 121
T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. 121
Frequent coexpression of cytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones. 121
Receptors for immunoglobulins on resting and activated human T cells. 121
Human natural killer cells: their origin, receptors and function 120
NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation 120
Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture. 119
Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. 119
Human peripheral blood lymphocytes bearing T cell receptor gamma/delta. Expression of CD8 differentiation antigen correlates with the expression of the 55-kD, C gamma 2-encoded gamma chain. 119
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin. 118
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 118
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 117
Surface receptors and functional interactions of human natural killer cells: from bench to the clinic 117
Human natural killer cells: origin, receptors, function, and clinical applications. 117
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 117
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 117
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 116
Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. 116
Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantation. 116
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients 116
Identification of diverse innate lymphoid cells in human decidua. 115
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. 115
Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells 114
Dendritic cells efficiently cross-prime HLA class I restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. 114
Anticlonotypic monoclonal antibodies induce proliferation of clonotype-positive T cells in peripheral blood human T lymphocytes. Evidence for a phenotypic (T4/T8) heterogeneity of the clonotype-positive proliferating cells. 114
Involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions: effect of anti-T11 monoclonal antibody on functional capabilities of alloreactive T cell clones. 114
Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations. 114
NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity. 114
Unsung hero Robert C. Gallo 114
Effect of tyrosin kinase inhibitors on NK Cell and ILC3 development and function 114
Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. 113
Human natural killer cell function and receptors. 113
Immune response in the conjunctival epithelium of patients with dry eye. 113
How melanoma cells inactivate NK cells 113
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 113
Different checkpoints in human NK-cell activation 112
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors. 112
null 111
Natural killer cells in human pregnancy. 111
Totale 12.905
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.673
article - articoli 88.555
book - libri 0
conference - conferenze 1.272
curatela - curatele 0
other - altro 0
patent - brevetti 525
selected - selezionate 0
volume - volumi 1.321
Totale 183.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.127 0 0 0 0 816 888 1.317 592 781 1.464 933 336
2020/20212.449 130 221 260 188 178 219 104 214 239 274 213 209
2021/20224.034 129 283 374 399 202 205 243 962 165 392 172 508
2022/20233.533 375 227 63 324 569 697 2 266 602 13 352 43
2023/20241.857 118 248 49 251 174 336 73 88 125 45 95 255
2024/20251.624 99 431 193 338 563 0 0 0 0 0 0 0
Totale 32.010